What is the appropriate dosing regimen of acyclovir (Zovirax) for treating chickenpox?

How to Give Zovirax (Acyclovir) for Chickenpox

Acyclovir should be given orally at 20 mg/kg four times daily (maximum 800 mg per dose) for 5 days, but ONLY if started within 24 hours of rash onset and ONLY for specific high-risk groups—not for routine use in healthy children.

Critical Timing Window

The effectiveness of acyclovir is entirely dependent on when treatment begins:

• Within 24 hours of rash onset: Proven benefit in reducing disease severity 1
• After 24 hours: No clinical benefit demonstrated 2

This 24-hour window is non-negotiable. Starting treatment on day 2 or 3 of illness provides no meaningful improvement in outcomes 2.

Who Should Receive Treatment

Immunocompromised Patients (ALWAYS TREAT)

• Use intravenous acyclovir at 10-15 mg/kg or 500 mg/m² IV every 8 hours
• Start within 24 hours of rash onset
• This is the only population where acyclovir reduces morbidity and mortality 1

High-Risk Otherwise Healthy Patients (CONSIDER TREATMENT)

According to AAP guidelines, oral acyclovir should be considered for 1:

• Persons aged ≥12 years (adolescents and adults)
• Chronic cutaneous or pulmonary disorders
• Long-term salicylate therapy
• Short, intermittent, or aerosolized corticosteroid courses
• Secondary household cases (some experts recommend)

Healthy Children Under 12 Years (DO NOT ROUTINELY TREAT)

AAP explicitly does not recommend routine acyclovir for otherwise healthy children despite FDA approval 1. While studies show modest reductions in fever duration and lesion counts 3, the clinical benefit is insufficient to justify routine use because:

• Complications occur in only 1-2% of cases
• Treatment doesn't reduce transmission or school absence
• The disease is generally mild and self-limiting

Dosing Regimen

Oral Acyclovir (for eligible patients)

• Children: 20 mg/kg four times daily (maximum 800 mg per dose)
• Adolescents and Adults: 800 mg five times daily
• Duration: 5 days is sufficient; 7 days provides no additional benefit 4
• Must start within 24 hours of rash onset

Intravenous Acyclovir (immunocompromised or severe complications)

• Dose: 10-15 mg/kg or 500 mg/m² IV every 8 hours
• Duration: 5-10 days
• Can transition to oral after minimum 48 hours IV if: afebrile, no new lesions for 24 hours, no organ involvement, tolerating oral intake 5

Special Populations

Pregnancy

• Oral acyclovir: Not routinely recommended 1
• IV acyclovir: Consider for serious complications like pneumonitis 6
• Category B drug; registry data shows no increased birth defects 1
• For severe varicella pneumonitis: 10-15 mg/kg IV every 8 hours, start within 24-72 hours of rash onset 6

Neonates

• Administer varicella zoster immunoglobulin if maternal disease onset is 5 days before to 2 days after delivery 6
• Acyclovir treatment follows immunocompromised dosing if infection develops

Common Pitfalls to Avoid

1. Starting treatment too late: After 24 hours, you've missed the window—don't bother 2
2. Treating healthy young children routinely: This goes against AAP recommendations and wastes resources 1
3. Using topical acyclovir ointment: The FDA label 7 is for herpes simplex, not varicella—topical formulations are ineffective for chickenpox
4. Expecting prevention of complications: Studies couldn't demonstrate reduced complication rates due to their rarity (1-2%) 1, 3
5. Prophylactic use: Acyclovir is NOT indicated for post-exposure prophylaxis; vaccination is the method of choice 1

What Acyclovir Actually Does

When given within 24 hours to appropriate patients, acyclovir:

• Reduces time to no new lesions by 1 day
• Decreases total lesion count by approximately 15-46% 8, 2
• Shortens fever duration by 1-2 days
• Accelerates progression to crusting and healing
• Does NOT reduce transmission, school absence, or antibody response 1, 3

Bottom Line Algorithm

Is the patient immunocompromised?

• YES → IV acyclovir immediately (within 24 hours of rash)
• NO → Continue below

Is rash onset <24 hours ago?

• NO → Supportive care only; acyclovir won't help
• YES → Continue below

Does patient meet high-risk criteria (age ≥12, chronic lung/skin disease, on salicylates/steroids)?

• YES → Oral acyclovir 20 mg/kg QID × 5 days (max 800 mg/dose)
• NO → Supportive care only; do not treat